• 1
    Kaufman DS, Hanson ET, Lewis RL et al. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2001; 98: 1071610721.
  • 2
    Vodyanik MA, Bork JA, Thomson JA et al. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 2005; 105: 617626.
  • 3
    Tian X, Morris JK, Linehan JL et al. Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cells. Exp Hematol 2004; 32: 10001009.
  • 4
    Qiu C, Hanson E, Olivier E et al. Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Exp Hematol 2005; 33: 14501458.
  • 5
    Woll PS, Morris JK, Painschab MS et al. Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood 2008; 111: 122131.
  • 6
    Woll PS, Martin CH, Miller JS et al. Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity. J Immunol 2005; 175: 50955103.
  • 7
    Olivier EN, Qiu C, Velho M et al. Large-scale production of embryonic red blood cells from human embryonic stem cells. Exp Hematol 2006; 34: 16351642.
  • 8
    Anderson JS, Bandi S, Kaufman DS et al. Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy. Retrovirology 2006; 3: 24.
  • 9
    Gaur M, Kamata T, Wang S et al. Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. J Thromb Haemost 2006; 4: 436442.
  • 10
    Wang L, Li L, Shojaei F et al. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 2004; 21: 3141.
  • 11
    Kennedy M, D'Souza SL, Lynch-Kattman M et al. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 2007; 109: 26792687.
  • 12
    Zambidis ET, Soon Park T, Yu W et al. Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 2008; 112: 36013614.
  • 13
    Lu SJ, Feng Q, Caballero S et al. Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods 2007; 4: 501509.
  • 14
    Vormoor J, Lapidot T, Pflumio F et al. SCID mice as an in vivo model of human cord blood hematopoiesis. Blood Cells 1994; 20: 316320, discussion 320–312.
  • 15
    Lapidot T, Pflumio F, Doedens M et al. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 1992; 255: 11371141.
  • 16
    Bhatia M, Wang JC, Kapp U et al. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 1997; 94: 53205325.
  • 17
    Larochelle A, Vormoor J, Hanenberg H et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med 1996; 2: 13291337.
  • 18
    Bhatia M, Bonnet D, Murdoch B et al. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998; 4: 10381045.
  • 19
    Kimura T, Asada R, Wang J et al. Identification of long-term repopulating potential of human cord blood-derived CD34-flt3- severe combined immunodeficiency-repopulating cells by intra-bone marrow injection. Stem Cells 2007; 25: 13481355.
  • 20
    Mazurier F, Doedens M, Gan OI et al. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med 2003; 9: 959963.
  • 21
    Hogan CJ, Shpall EJ, Keller G. Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice. Proc Natl Acad Sci USA 2002; 99: 413418.
  • 22
    de Wynter EA, Buck D, Hart C et al. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating Cells And Dendritic Cell Progenitors. Stem Cells 1998; 16: 387396.
  • 23
    Tian X, Woll PS, Morris JK et al. Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity. Stem Cells 2006; 24: 13701380.
  • 24
    Wang L, Menendez P, Shojaei F et al. Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J Exp Med 2005; 201: 16031614.
  • 25
    Narayan AD, Chase JL, Lewis RL et al. Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood 2006; 107: 21802183.
  • 26
    Ji J, Vijayaragavan K, Bosse M et al. OP9 Stroma augments survival of hematopoietic precursors and progenitors during hematopoietic differentiation from human embryonic stem cells. Stem Cells 2008; 26: 24852495.
  • 27
    Ledran MH, Krassowska A, Armstrong L et al. Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell 2008; 3: 8598.
  • 28
    Hiramatsu H, Nishikomori R, Heike T et al. Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/γc-null mice model. Blood 2003; 102: 873880.
  • 29
    Yahata T, Ando K, Nakamura Y et al. Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 Receptor Gamma Null Mice. J Immunol 2002; 169: 204209.
  • 30
    Pearson T, Greiner DL, Shultz LD. Creation of “humanized” mice to study human immunity. Curr Protoc Immunol 2008;Chapter 15:Unit 15.21.
  • 31
    Wilber A, Linehan JL, Tian X et al. Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem Cells 2007; 25: 29192927.
  • 32
    Tian X, Kaufman DS. Hematopoietic development of human embryonic stem cells in culture. Methods Mol Biol 2008; 430: 119133.
  • 33
    Traggiai E, Chicha L, Mazzucchelli L et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004; 304: 104107.
  • 34
    Zambidis ET, Sinka L, Tavian M et al. Emergence of human angiohematopoietic cells in normal development and from cultured embryonic stem cells. Ann N Y Acad Sci 2007; 1106: 223232.
  • 35
    Yoder MC, Hiatt K, Mukherjee P. In vivo repopulating hematopoietic stem cells are present in the murine yolk sac at day 9.0 postcoitus. Proc Natl Acad Sci USA 1997; 94: 67766780.
  • 36
    Trivedi P, Hematti P. Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp Hematol 2007; 35: 146154.
  • 37
    Ramshaw HS, Haylock D, Swart B et al. Monoclonal antibody BB9 raised against bone marrow stromal cells identifies a cell-surface glycoprotein expressed by primitive human hemopoietic progenitors. Exp Hematol 2001; 29: 981992.
  • 38
    Sharma S, Gurudutta GU, Satija NK et al. Stem cell c-KIT and HOXB4 genes: Critical roles and mechanisms in self-renewal, proliferation, and differentiation. Stem Cells Dev 2006; 15: 755778.
  • 39
    Slukvin II, Vodyanik MA, Thomson JA et al. Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway. J Immunol 2006; 176: 29242932.
  • 40
    Galic Z, Kitchen SG, Kacena A et al. T lineage differentiation from human embryonic stem cells. Proc Natl Acad Sci USA 2006; 103: 1174211747.
  • 41
    Ishikawa F, Yasukawa M, Lyons B et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chain(null) mice. Blood 2005; 106: 15651573.
  • 42
    Manz MG. Human-hemato-lymphoid-system mice: Opportunities and challenges. Immunity 2007; 26: 537541.
  • 43
    Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol 2007; 7: 118130.
  • 44
    Liu CH, Hwang SM. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 2005; 32: 270279.
  • 45
    Bensidhoum M, Chapel A, Francois S et al. Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood 2004; 103: 33133319.
  • 46
    Angelopoulou M, Novelli E, Grove JE et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol 2003; 31: 413420.
  • 47
    Noort WA, Kruisselbrink AB, in't Anker PS et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002; 30: 870878.
  • 48
    Fibbe WE, Noort WA. Mesenchymal stem cells and hematopoietic stem cell transplantation. Ann N Y Acad Sci 2003; 996: 235244.